Neghizyl (Ibuprofen Lysine)

Ibuprofen lysine works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels lead to decreased inflammation, pain signaling, and fever.

The appropriate dose of Neghizyl is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety of ibuprofen lysine in pregnancy and lactation has not been definitively established. Healthcare providers usually weigh potential benefits against risks and may recommend alternative therapies, especially during the third trimester or while nursing.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Neghizyl delivers ibuprofen in a lysine salt form, which can provide faster absorption compared with standard ibuprofen tablets. Its efficacy for pain, fever, and inflammation is comparable to other NSAIDs, while the safety profile follows the class‑wide considerations for gastrointestinal, renal, and cardiovascular risks.

Neghizyl should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in humid environments.

Neghizyl is taken orally, usually with a full glass of water. Depending on the formulation, it may be recommended to take it with food to lessen gastrointestinal irritation, but patients should follow the specific instructions provided by their healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, acute kidney injury, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as vomiting blood, severe abdominal pain, rash, or difficulty breathing.

Neghizyl is contraindicated in individuals with known hypersensitivity to ibuprofen, other NSAIDs, or aspirin, as well as those with active gastrointestinal bleeding, severe heart failure, or advanced renal impairment. Consultation with a healthcare professional is essential before initiating therapy in these populations.